Overview

Copd Exacerbation and Pulmonary Hypertension Trial

Status:
Recruiting
Trial end date:
2025-10-31
Target enrollment:
Participant gender:
Summary
This trial will investigate whether patiens admitted with an acute exacerbation of chronic obstructive lung disease and pulmonary hypertension will benefit from a targeted pharmacological treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Treatments:
Sildenafil Citrate